This paper aims to document accurately the soft tissue anatomy and bony attachments of the posterior belly of the digastric muscle and other closely related muscles in the mastoid region of extant hominoids and fossil hominids. Five wet specimens including individuals of Pan, Gorilla and Pongo were dissected and described. Eight casts of fossil hominid cranial bases were also studied along with measurements and notes made from the same original fossil hominid specimens to assess their soft tissue markings in the light of the findings for the three great apes. The results indicate that whereas the attachment of the posterior belly of the digastric muscle in Homo sapiens is associated with a deep groove or fossa, it originates from a widened area and leaves no bony markings on the cranial base of the three great apes. Following a change in the position of the foramen magnum and the occipital condyles in hominids and H. sapiens the insertion of the posterior belly of the digastric has remained posteriorly positioned but has become compressed into a deep groove. It is likely that this has come about by the displacement of the more medial soft tissue structures which have been moved laterally away from the occipital condyles.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.